Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals

Authors

J.-M. L’Orphelin (ORCID: https://orcid.org/0000-0002-5680-7888)
Angélique Da Silva (ORCID: https://orcid.org/0000-0002-8193-5144)
Charles Dolladille (ORCID: https://orcid.org/0000-0003-0449-6261)
Joachim Alexandre (ORCID: https://orcid.org/0000-0002-9197-8404)
Jean Cabon (ORCID: https://orcid.org/0009-0004-9933-7996)

Institutions

Physiopathologie et Stratégies d'Imagerie du Remodelage cardiovasculaire
Université de Caen Normandie (FR)

Publication Details

Journal: BMJ Open
Published: 2024-12-01
DOI: https://doi.org/10.1136/bmjopen-2024-091708
Citations: 6
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 1.70

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals

J.-M. L’Orphelin, Angélique Da Silva, Charles Dolladille, Joachim Alexandre et al.

Dec 1, 2024

6 citations

BMJ Open

Cancer Immunotherapy and Biomarkers

1.70

article

Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals

J.-M. L’Orphelin, Angélique Da Silva, Charles Dolladille, Joachim Alexandre, Jean Cabon

December 1, 2024article en

6 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 14(12)

Physiopathologie et Stratégies d'Imagerie du Remodelage cardiovasculaire, Université de Caen Normandie (FR)

Good health and well-being

Openalex Percentile: Top 13%

Cancer Immunotherapy and Biomarkers

1.70

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals — J.-M. L’Orphelin, Angélique Da Silva, et al. · BMJ Open (2024) | TGRS Research Map | TGRS